Concepedia

PLASMA CONCENTRATIONS OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN RETINOPATHY OF PREMATURITY AFTER INTRAVITREAL BEVACIZUMAB INJECTION

Yoo Rha Hong, Young Ho Kim, Soo Young Kim, Gi Yup Nam, Hee Jong Cheon, Sang Joon Lee

Retina · 2015 · 67 citations · 12 references

DOI

Abstract

Intravitreal bevacizumab injections significantly reduce plasma VEGF concentration in infants with retinopathy of prematurity over a 7-week period.

References

12

Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity

Helen A. Mintz-Hittner, Kathleen A. Kennedy, Alice Z. Chuang · New England Journal of Medicine · 2011 · 1.4K citations · Full text

VEGF is required for growth and survival in neonatal mice

Hans‐Peter Gerber, Kenneth J. Hillan, Anne Ryan et al. · Development · 1999 · 915 citations

VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature

Tomomi Kamba, Betty Y. Tam, Hiroya Hashizume et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2005 · 766 citations

, , +18

Vascular Endothelial Growth Factor Expression in the Retinal Pigment Epithelium Is Essential for Choriocapillaris Development and Visual Function

Alexander G. Marneros, Jie Fan, Yoshihito Yokoyama et al. · American Journal Of Pathology · 2005 · 355 citations

, , +9

Serum Concentrations of Bevacizumab (Avastin) and Vascular Endothelial Growth Factor in Infants With Retinopathy of Prematurity

Tatsuhiko Sato, Kazuko Wada, Hitomi Arahori et al. · American Journal of Ophthalmology · 2011 · 321 citations

, , +7